Biological characterization of oxidized hyaluronic acid/resveratrol hydrogel for cartilage tissue engineering

Shiow Yunn Sheu, Wen Shan Chen, Jui Sheng Sun, Feng Huei Lin, Tuoh Wu

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Osteoarthritis is a type of arthritis that is caused by breakdown of cartilage, with eventual loss of the cartilage of the joints. The ability of self-repair in damaged cartilage tissue is limited; the aim of this work is to fabricate and characterize an oxidized hyaluronic acid/resveratrol (Oxi-HA/Res) hydrogel for future applications in cartilage tissue engineering. Under physiological conditions, the Oxi-HA/Res hydrogel was prepared by chemical crosslinking of Oxi-HA with resveratrol solution and characterized by Fourier transform infrared spectrometry assay; the biocompatibility and gene expression of chondrocytes within the Oxi-HA-Res hydrogel then analyzed. The cell viability and cytotoxicity assays showed that the Oxi-HA/Res hydrogel has good biocompatibility. Oxi-HA/Res hydrogel can upregulate expression of type II collagen, aggrecan, and Sox-9 genes; while down-regulating IL-1β, MMP-1, MMP-3, MMP13 gene expression. It can also reduce LPS-induced inflammation and chondrocyte damage. The results of this study showed that the Oxi-HA/Res hydrogel is biocompatible with chondrocytes, allows for extracellular matrix synthesis, and also reduce LPS-induced inflammation and damage. These results suggest that Oxi-HA/Res hydrogel may be a potential suitable cell carrier for chondrocyte cells in the treatment of cartilage defect. However, further in vivo study is mandatory for future possible clinical applications. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 3457-3466, 2013.

Original languageEnglish
Pages (from-to)3457-3466
Number of pages10
JournalJournal of Biomedical Materials Research - Part A
Volume101
Issue number12
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Resveratrol
Hyaluronic acid
Hydrogel
Cartilage
Hyaluronic Acid
Tissue engineering
Hydrogels
Matrix Metalloproteinases
Biocompatibility
Gene expression
Assays
Aggrecans
Collagen Type II
Cytotoxicity
resveratrol
Interleukin-1
Collagen
Crosslinking
Spectrometry
Fourier transforms

Keywords

  • cartilage tissue engineering
  • hyaluronic acid
  • injectable
  • resveratrol

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Ceramics and Composites
  • Metals and Alloys

Cite this

Biological characterization of oxidized hyaluronic acid/resveratrol hydrogel for cartilage tissue engineering. / Sheu, Shiow Yunn; Chen, Wen Shan; Sun, Jui Sheng; Lin, Feng Huei; Wu, Tuoh.

In: Journal of Biomedical Materials Research - Part A, Vol. 101, No. 12, 12.2013, p. 3457-3466.

Research output: Contribution to journalArticle

@article{1e2ac9e5dc1a401b817ca1a0ba2083ff,
title = "Biological characterization of oxidized hyaluronic acid/resveratrol hydrogel for cartilage tissue engineering",
abstract = "Osteoarthritis is a type of arthritis that is caused by breakdown of cartilage, with eventual loss of the cartilage of the joints. The ability of self-repair in damaged cartilage tissue is limited; the aim of this work is to fabricate and characterize an oxidized hyaluronic acid/resveratrol (Oxi-HA/Res) hydrogel for future applications in cartilage tissue engineering. Under physiological conditions, the Oxi-HA/Res hydrogel was prepared by chemical crosslinking of Oxi-HA with resveratrol solution and characterized by Fourier transform infrared spectrometry assay; the biocompatibility and gene expression of chondrocytes within the Oxi-HA-Res hydrogel then analyzed. The cell viability and cytotoxicity assays showed that the Oxi-HA/Res hydrogel has good biocompatibility. Oxi-HA/Res hydrogel can upregulate expression of type II collagen, aggrecan, and Sox-9 genes; while down-regulating IL-1β, MMP-1, MMP-3, MMP13 gene expression. It can also reduce LPS-induced inflammation and chondrocyte damage. The results of this study showed that the Oxi-HA/Res hydrogel is biocompatible with chondrocytes, allows for extracellular matrix synthesis, and also reduce LPS-induced inflammation and damage. These results suggest that Oxi-HA/Res hydrogel may be a potential suitable cell carrier for chondrocyte cells in the treatment of cartilage defect. However, further in vivo study is mandatory for future possible clinical applications. {\circledC} 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 3457-3466, 2013.",
keywords = "cartilage tissue engineering, hyaluronic acid, injectable, resveratrol",
author = "Sheu, {Shiow Yunn} and Chen, {Wen Shan} and Sun, {Jui Sheng} and Lin, {Feng Huei} and Tuoh Wu",
year = "2013",
month = "12",
doi = "10.1002/jbm.a.34653",
language = "English",
volume = "101",
pages = "3457--3466",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "1552-4973",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Biological characterization of oxidized hyaluronic acid/resveratrol hydrogel for cartilage tissue engineering

AU - Sheu, Shiow Yunn

AU - Chen, Wen Shan

AU - Sun, Jui Sheng

AU - Lin, Feng Huei

AU - Wu, Tuoh

PY - 2013/12

Y1 - 2013/12

N2 - Osteoarthritis is a type of arthritis that is caused by breakdown of cartilage, with eventual loss of the cartilage of the joints. The ability of self-repair in damaged cartilage tissue is limited; the aim of this work is to fabricate and characterize an oxidized hyaluronic acid/resveratrol (Oxi-HA/Res) hydrogel for future applications in cartilage tissue engineering. Under physiological conditions, the Oxi-HA/Res hydrogel was prepared by chemical crosslinking of Oxi-HA with resveratrol solution and characterized by Fourier transform infrared spectrometry assay; the biocompatibility and gene expression of chondrocytes within the Oxi-HA-Res hydrogel then analyzed. The cell viability and cytotoxicity assays showed that the Oxi-HA/Res hydrogel has good biocompatibility. Oxi-HA/Res hydrogel can upregulate expression of type II collagen, aggrecan, and Sox-9 genes; while down-regulating IL-1β, MMP-1, MMP-3, MMP13 gene expression. It can also reduce LPS-induced inflammation and chondrocyte damage. The results of this study showed that the Oxi-HA/Res hydrogel is biocompatible with chondrocytes, allows for extracellular matrix synthesis, and also reduce LPS-induced inflammation and damage. These results suggest that Oxi-HA/Res hydrogel may be a potential suitable cell carrier for chondrocyte cells in the treatment of cartilage defect. However, further in vivo study is mandatory for future possible clinical applications. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 3457-3466, 2013.

AB - Osteoarthritis is a type of arthritis that is caused by breakdown of cartilage, with eventual loss of the cartilage of the joints. The ability of self-repair in damaged cartilage tissue is limited; the aim of this work is to fabricate and characterize an oxidized hyaluronic acid/resveratrol (Oxi-HA/Res) hydrogel for future applications in cartilage tissue engineering. Under physiological conditions, the Oxi-HA/Res hydrogel was prepared by chemical crosslinking of Oxi-HA with resveratrol solution and characterized by Fourier transform infrared spectrometry assay; the biocompatibility and gene expression of chondrocytes within the Oxi-HA-Res hydrogel then analyzed. The cell viability and cytotoxicity assays showed that the Oxi-HA/Res hydrogel has good biocompatibility. Oxi-HA/Res hydrogel can upregulate expression of type II collagen, aggrecan, and Sox-9 genes; while down-regulating IL-1β, MMP-1, MMP-3, MMP13 gene expression. It can also reduce LPS-induced inflammation and chondrocyte damage. The results of this study showed that the Oxi-HA/Res hydrogel is biocompatible with chondrocytes, allows for extracellular matrix synthesis, and also reduce LPS-induced inflammation and damage. These results suggest that Oxi-HA/Res hydrogel may be a potential suitable cell carrier for chondrocyte cells in the treatment of cartilage defect. However, further in vivo study is mandatory for future possible clinical applications. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 3457-3466, 2013.

KW - cartilage tissue engineering

KW - hyaluronic acid

KW - injectable

KW - resveratrol

UR - http://www.scopus.com/inward/record.url?scp=84886729199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886729199&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.34653

DO - 10.1002/jbm.a.34653

M3 - Article

C2 - 23595953

AN - SCOPUS:84886729199

VL - 101

SP - 3457

EP - 3466

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 1552-4973

IS - 12

ER -